Skip to content

CVRx, Inc. CVRX Enterprise value

Enterprise value at other companies

Abbott logo
AbbottABT
$205.65B-13.1%
Boston Scientific logo
Boston ScientificBSX
$141.04B-1.0%
Medtronic logo
MedtronicMDT
$131.22B-3.2%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$497.55M+11.5%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$577.67M-23.8%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
$1.42B-70.0%

Other financials

Income statement

See full
Revenue$14.8M+19.6%
Gross profit$12.9M+24.9%
Operating income-$12.2M+9.5%
Net income-$13.1M+4.7%
EPS (diluted)-$0.50+5.7%

Balance sheet

See full
Cash & equivalents$72.3M-29.6%
Total debt$59.4M+17.8%
Total equity$29.1M-58.0%
Total assets$99.7M-23.0%

Cash flow

See full
Operating cash flow-$12.2M+4.7%
CapEx$122.0K+7.0%
Free cash flow-$12.3M+4.6%

Valuation

See full
Market cap$148.6M-2.9%
P/S2.5×-0.3×

Profitability

See full
Gross margin86.2%+2.7pp
Operating margin-84.6%-8.9pp
Net margin-89.1%-7.0pp
FCF margin-68%-8.1pp

Returns & leverage

See full
Return on equity-107%+73.4pp
Debt / equity+1.3×
Current ratio10.2×-4.6×

Where this comes from

Calculated from CVRx, Inc.’s reported figures.

The official record: CVRx, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about CVRx, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CVRx, Inc.'s enterprise value?
CVRx, Inc. (CVRX) reported enterprise value of $236M in Q1 2026.
How has CVRx, Inc.'s enterprise value changed year-over-year?
CVRx, Inc.'s enterprise value decreased by 11.3% year-over-year, from $266.18M to $236M.
What is the long-term trend for CVRx, Inc.'s enterprise value?
Over 3 years (2022 to 2025), CVRx, Inc.'s enterprise value has grown at a -16.7% compound annual growth rate (CAGR), from $278.78M to $160.89M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.